TDK has announced the release of the TDK‑Lambda TPS4500 series of industrial AC‑DC power supplies, offering a rated output of ...

Preliminary shotgun metagenomic sequencing demonstrated that EBX-102-02 induced a broad and sustained shift in the gut ...

A stable "exceptional fermionic superfluid," a new quantum phase that intrinsically hosts singularities known as exceptional ...

EMA provided overall agreement with the proposed Phase 3 clinical trial of VCN-01 in combination with ...

Favorable safety, tolerability, pharmacokinetic and pharmacodynamic profiles validate and significantly de-risk the ...

Acesion Pharma has begun enrolling patients into a phase 2 clinical trial of AP31969, its novel oral SK ion channel inhibitor being developed for rhythm control in atrial fibrillation.

Theriva Biologics (TOVX) announced the receipt of Scientific Advice from the Committee for Medicinal Products for Human Use ...

Acesion Pharma ("Acesion" or "the Company"), a biotech company pioneering treatments for atrial fibrillation ("AF"), the most common cardiac arrhythmia, today announces enrolment of the first patients ...

The Union Cabinet chaired by the Prime Minister, Shri Narendra Modi has approved three new corridors – 1. R.K Ashram Marg to Indraprastha (9.913 Kms), 2. Aerocity to IGD Airport T-1 (2.263 ...

ISO New England Inc. (ISO-NE) recently requested that the Federal Energy Regulatory Commission (FERC) accept its first batch ...

Sparrow Pharmaceuticals, a targeted cardiometabolic therapeutics company, today announced that the first patient has been ...

EMA provided overall agreement with the proposed Phase 3 clinical trial of VCN-01 in combination with gemcitabine/nab-paclitaxel for the first-line treatment of metastatic PDAC, including sample size ...